Anh is a drug discovery leader and medicinal chemist with over 20 years of experience advancing small-molecule programs from target validation through clinical candidate nomination. She has led and contributed to the discovery of four small-molecule drug candidates that advanced into clinical trials at Neuron23, Janssen Pharmaceutical Companies of Johnson & Johnson, Alios BioPharma (acquired by Janssen), and Elan Pharmaceuticals. Her work has resulted in 20 patents and patent applications, as well as 27 peer-reviewed publications. Anh earned her Ph.D. in synthetic organic chemistry from the University of Utah under Professor Gary Keck. Outside of work, she enjoys cooking, traveling, and exploring new cuisines.